Market Cap

Excelsior Biopharma, Inc. Market Capitalization:

TW$1.35 Billion

TWD as of Jan. 1, 2024

US$44.1 Million

business Excelsior Biopharma, Inc. Company Profile

Excelsior Biopharma, Inc. Main Stock Listing

TWSE: 6496

Market Capitalization History of Excelsior Biopharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Excelsior Biopharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$1.35 B 5.79%
Jan. 1, 2023 TW$1.28 B -8.67%
Jan. 1, 2022 TW$1.40 B 9.29%
Jan. 1, 2021 TW$1.28 B -21.57%
Jan. 1, 2020 TW$1.63 B -26.39%
Jan. 1, 2019 TW$2.22 B -36.68%
Jan. 1, 2018 TW$3.51 B 24.13%
Jan. 1, 2017 TW$2.82 B -12.32%
Jan. 1, 2015 TW$3.22 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Excelsior Biopharma, Inc. Categories

Taiwan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Taiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic

Stocks & Indices

Excelsior Biopharma, Inc. has the following listings and related stock indices.


Stock: TWSE: 6496

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.